Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
BioCryst Pharmaceuticals, Inc. (BCRX) had Book Value Per Share of $-0.56 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$406.56M |
|
$245.84M |
|
$9.52M |
|
$397.03M |
|
$146.17M |
|
$260.38M |
|
$-12.37M |
|
$248.02M |
|
$248.02M |
|
$245.84M |
|
$245.84M |
|
$245.84M |
|
$245.84M |
|
$260.38M |
|
$259.69M |
|
209.89M |
|
218.58M |
|
$1.18 |
|
$1.13 |
|
| Balance Sheet Financials | |
$404.35M |
|
$8.78M |
|
$109.81M |
|
$514.16M |
|
$196.07M |
|
$428.67M |
|
$437.25M |
|
$633.31M |
|
$-119.15M |
|
$-119.15M |
|
$-119.15M |
|
213.06M |
|
| Cash Flow Statement Financials | |
$347.37M |
|
$-13.69M |
|
$-349.93M |
|
$106.32M |
|
$91.34M |
|
$-14.99M |
|
$85.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.06 |
|
-- |
|
-- |
|
1.39 |
|
-4.05 |
|
97.66% |
|
64.05% |
|
64.05% |
|
-- |
|
61.00% |
|
60.47% |
|
$345.45M |
|
-- |
|
-- |
|
-- |
|
0.79 |
|
1.76 |
|
3.81 |
|
23.65 |
|
-206.33% |
|
-206.33% |
|
47.82% |
|
79.43% |
|
|
Book Value Per Share |
$-0.56 |
$1.58 |
|
$1.59 |
|